1 December 2016
In a bid to increase transparency and facilitate regulatory oversight of the OTC derivative market, the introduction of mandatory reporting and data repositories is well intentioned. However, despite a huge effort from the industry to report their trade data, challenges persist.
Trade data often cannot be identified or matched against counterparties, discrepancies in terms are ubiquitous and the integrity of reporting is compromised.
As regulatory pressure mounts, TriOptima’s recent whitepaper discusses the issue and provides insight into how firms can overcome the challenges.
To download the whitepaper, please register below.